Philips strikes R&D pact

Article

Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell

Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell death.

The two companies hope to optimize techniques and instrumentation for using Apomate, an investigational in vivo nuclear medicine imaging agent that targets cells undergoing apoptosis or necrosis. Theseus will provide images and other data from its cardiac imaging trials of Apomate to Philips. Apomate images will be fused with images taken using thallium. The collaboration may result in methods that enhance Apomate imaging, leading to increased clinical acceptance and improved clinical outcomes when Apomate imaging is applied.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.